Upcoming Products

Pharmazz, Inc. is constantly engaged in improving its pipeline and sponsors research in various academic organizations.

The data captured in preclinical and clinical studies is constantly analyzed to generate new leads.

Some of the promising indications that are in developmental stage are acute kidney injury, postpartum hemorrhage, neonatal hypoxic-ischemic encephalopathy, traumatic brain injury, hearing loss, wound healing and other unmet medical needs.

Pharmazz, Inc. has a foot at the door with a commercial drug for hypovolemic shock with a chance to grab another indication of septic shock with a much bigger market size.